Suresh Dheerendra serves as the Senior Vice President of Clinical Operations at Neuron23. Suresh is a seasoned clinical operations leader with over 20 years of global clinical development experience across several established biotech and pharmaceutical companies, including: Genentech, Lundbeck, Takeda, and Abbott/AbbVie. He has led programs across a variety of therapeutic areas in all phases of development.
Prior to joining Neuron23, Suresh was a Clinical Program Director at Genentech leading multiple programs from entry into the clinic to late-stage development. Suresh holds a BS degree in Biology, (Plant Genetics), from Northern Illinois University and a MS degree in Health Care Administration from DePaul University.
Associated Grants
-
Expansion of the NEULARK Study, Examining the Effects of NEU-411 on LRRK2-driven Parkinson’s Patients, Into Israel
2026